Drug name - Veletri

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8598227 ACTELION Epoprostenol formulation and method of making thereof Feb, 2027

(4 years from now)

US8318802 ACTELION Epoprostenol formulation and method of making thereof Mar, 2027

(4 years from now)

Drugs and Companies using EPOPROSTENOL SODIUM ingredient

Treatment: NA

Dosage: INJECTABLE;INJECTION

More Information on Dosage
Strength Dosage Availability
EQ 0.5MG BASE/VIAL INJECTABLE;INJECTION Prescription
EQ 1.5MG BASE/VIAL INJECTABLE;INJECTION Prescription

availability in other generic markets.

Click on the highlighted region to filter.